Delivery Order SPE2DB22D1103-SPE2DB25FTLR0

Award Date 5/1/25
Potential Completion Date 5/2/25
Potential Value $4.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,706.43, is for the delivery of the diabetes medication Trulicity 4.5 mg/0.5 ml pen. The contract is a firm fixed-price delivery order with an ultimate completion date of April 28, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) between...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,024.53, is for the delivery of Trulicity 1.5 mg/0.5 ml pen 0.5 ml, a diabetes medication. The contract has a period of performance through May 1, 2025 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $8,450.66 contract is for the delivery of the diabetes medication Trulicity 1.5 mg/0.5 ml pen. The contract has a completion date of March 28, 2023 and utilizes a firm fixed price pricing type. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical has awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,368.08 firm fixed-price contract is for the supply of the diabetes medication Trulicity 1.5 mg/0.5 ml pens. This Delivery Order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,849.73, is for the delivery of the diabetes medication Trulicity 1.5 mg/0.5 ml pen. The contract is a firm fixed-price delivery order with an ultimate completion date of April 7, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the diabetes medication Trulicity 1.5 mg/0.5 ml pen. The contract has a firm fixed price of $1,801.80 and a period of performance through April 17, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,702.70 firm-fixed-price contract is for the supply of the diabetes medication Trulicity 0.75 mg/0.5 ml pen. The contract has an ultimate completion date of April 21, 2025 and was awarded on April 18, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 1.5 mg/0.5 ml pen 0.5 ml, a diabetes medication. The contract has a firm fixed price of $3,967.20 and a completion date of April 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the Type 2 diabetes medication Trulicity (1.5 mg/0.5 ml pen, 0.5 ml). The contract has a ceiling value of $3,149.44 and an ultimate completion date of August 8, 2022. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,865.35 and covers the supply of the diabetes medication Trulicity 1.5 mg/0.5 ml pen. The contract is not set aside and was awarded on April 16, 2025, with a final completion date of April 17, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB25FTLR0
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,504.50, is for the delivery of the diabetes medication Trulicity (3 mg/0.5 mL pen, 0.5 mL). The contract is a firm fixed-price, non-set-aside delivery order with a performance period through May 2, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military and government healthcare programs through December 2026.

Generated 7/31/25, 10:30 AM